1.
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
by Sarwar, Nadeem
The Lancet (British edition), 2010, Vol.375 (9726), p.1634-1639
2.
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
by Sabatine, Marc S., MD, MPH
The American heart journal, 2015, Vol.173, p.94-101
3.
The Association Between Air Pollution Exposure and Glucose and Lipids Levels
by Yitshak Sade, Maayan
The journal of clinical endocrinology and metabolism, 2016-06, Vol.101 (6), p.2460-2467
4.
Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits
by Mancuso, Nicholas
American journal of human genetics, 2017-03-02, Vol.100 (3), p.473-487
5.
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
by Borén, Jan
Nature (London), 2002-06-13, Vol.417 (6890), p.750-754
6.
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets
by Colas, R
Diabetologia, 2011-08-17, Vol.54 (11), p.2931-2940
7.
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and desi...
by Ridker, Paul M
The American heart journal, 2016-08, Vol.178, p.135-144
8.
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
by Bril, Fernando
The journal of clinical endocrinology and metabolism, 2016-02, Vol.101 (2), p.644-652
9.
Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis
by Li, Na
Clinical rheumatology, 2022-01-07, Vol.41 (3), p.677-688
10.
Lipids and HCV
by Bassendine, M. F
Seminars in immunopathology, 2012-10-31, Vol.35 (1), p.87-100
11.
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
by Ooi, Esther M. M
The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.E1568-E1576
12.
Increased Visceral Adipose Tissue Is an Independent Predictor for Future Development of Atherogenic Dyslipidemia
by Hwang, You-Cheol
The journal of clinical endocrinology and metabolism, 2016-02, Vol.101 (2), p.678-685
13.
Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-...
by Valls, Rosa-M
Phytomedicine (Stuttgart), 2016-11-15, Vol.23 (12), p.1451-1461
14.
Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids
by Jackisch, Laura
Diabetologia, 2018-02-09, Vol.61 (5), p.1155-1166
15.
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes : relationship to elevated oxidative stress and hyperglycaemia
by NOBECOURT, E
Diabetologia, 2005, Vol.48 (3), p.529-538
16.
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins
by Fazio, Sergio
The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3340-3348
17.
Copeptin predicts coronary artery disease cardiovascular and total mortality
by Tasevska, Irina
Heart (British Cardiac Society), 2016-01, Vol.102 (2), p.127-132
18.
Hypoglycemic and hypolipidemic effect of Vaccinium myrtillus L. leaf and Phaseolus vulgaris L. seed coat extracts in diabetic rats
by Sidorova, Yulia, Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2017, Vol.41, p.107-112
19.
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)
by Mosca, Lori, MD, MPH, PhD
The American journal of cardiology, 2016, Vol.119 (3), p.397-403
20.
Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance
by Scheuer, Stine H
The journal of clinical endocrinology and metabolism, 2015-09, Vol.100 (9), p.3340-3347
